Article

Cellular and Humoral Responses to SARS-CoV-2 Vaccination in Immunosuppressed Patients

2022-01-07

Abstract excerpt

<title>Abstract</title> <p><bold>Objective: </bold>SARS-CoV-2 vaccinations have demonstrated vaccine-immunogenicity in healthy volunteers, however, efficacy in immunosuppressed patients is less well characterised. There is an urgent need to address the impact of immunosuppression on vaccine immunogenicity. <bold>Methods: </bold>Serological, T-cell ELISpot, cytokines and immunophenotyping assays were used to asses...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: df35942b-bee0-5887-a30e-c416b96cd4e8
DOI: 10.21203/rs.3.rs-1152342/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cellular and Humoral Responses to SARS-CoV-2 Vaccination in Immunosuppressed PatientsDOI 10.21203/rs.3.rs-1152342/v1Read

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patientsSemantic proximity Read

Distinct Patterns of Humoral and Cellular Immune Responses Following SARS-CoV-2 mRNA Vaccination in Patients With Immune-Mediated Neurological Disorders on Anti-CD20 Therapy: A Prospective Cohort StudySemantic proximity Read

B and T cell responses after a third dose of SARS-CoV-2 vaccine in Kidney Transplant RecipientsSemantic proximity Read

Cellular immune response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity Read

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trialSemantic proximity Read

HUMORAL AND CELLULAR IMMUNOGENICITY and SAFETY UP TO 4 MONTHS AFTER VACCINATION WITH BNT162B2 mRNA COVID-19 VACCINE IN HEART AND LUNG TRANSPLANTED YOUNG ADULTSSemantic proximity Read

Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus InfectionSemantic proximity Read

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVSemantic proximity Read

Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.Semantic proximity Read

Immunogenicity and reactogenicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescentsSemantic proximity Read

Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipientsSemantic proximity Read